This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meis, J F Articles by Veth, R P Search for Related Content PubMed PubMed Citation Articles by Meis, J F Articles by Veth, R P

Severe osteomyelitis due to the zygomycete Apophysomyces elegans.

Department of Medical Microbiology, University Hospital St. Radboud, Nijmegen, The Netherlands.

ABSTRACT

We describe a previously healthy 69-year-old man presenting with osteomyelitis of the humerus due to the zygomycete Apophysomyces elegans. The infection was acquired in Aruba, The Netherlands Antilles. The skin provided the most likely portal of entry, although there was no history of a traumatic inoculation. The patient had no history of diabetes, and no underlying immune defects were found. Despite treatment with 7.9 g of amphotericin B, an interthoracoscapular amputation proved necessary to curtail the rapid spread of the fungus in this immunocompetent host.

This article has been cited by other articles:

• Liang, K. P., Tleyjeh, I. M., Wilson, W. R., Roberts, G. D., Temesgen, Z. (2006). Rhino-Orbitocerebral Mucormycosis Caused by Apophysomyces elegans.. J. Clin. Microbiol. 44: 892-898 [Abstract] [Full Text]  
• Chakrabarti, A., Ghosh, A., Prasad, G. S., David, J. K., Gupta, S., Das, A., Sakhuja, V., Panda, N. K., Singh, S. K., Das, S., Chakrabarti, T. (2003). Apophysomyces elegans: an Emerging Zygomycete in India. J. Clin. Microbiol. 41: 783-788 [Abstract] [Full Text]  
• Dannaoui, E., Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Verweij, P. E., the Eurofung Network, (2003). In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 51: 45-52 [Abstract] [Full Text]  
• Dannaoui, E., Mouton, J. W., Meis, J. F. G. M., Verweij, P. E. (2002). Efficacy of Antifungal Therapy in a Nonneutropenic Murine Model of Zygomycosis. Antimicrob. Agents Chemother. 46: 1953-1959 [Abstract] [Full Text]  
• Dannaoui, E., Meis, J. F. G. M., Mouton, J. W., Verweij, P. E., the Eurofung Network, (2002). In vitro susceptibilities of Zygomycota to polyenes. J Antimicrob Chemother 49: 741-744 [Abstract] [Full Text]  
• Ribes, J. A., Vanover-Sams, C. L., Baker, D. J. (2000). Zygomycetes in Human Disease. Clin. Microbiol. Rev. 13: 236-301 [Abstract] [Full Text]  
• Cimerman, M., Gunde-Cimerman, N., Zalar, P., Perkovic, T. (1999). Femur Osteomyelitis Due to a Mixed Fungal Infection in a Previously Healthy Man. J. Clin. Microbiol. 37: 1532-1535 [Abstract] [Full Text]